Subscribe to Newsletter

November 2020 Issue of The Medicine Maker

In the month’s issue, we examine what lessons from pandemic influenza can be applied to COVID-19 – featuring Russell Basser from Seqirus. We then move far beyond the pandemic to deep space – asking how biologic medicines can be made on-demand for astronauts on long-term space missions. In Profession, Ross T. Burn, CEO at CatSci walks us through the career experiences that have helped shape him, and in NextGen, we find out what can be done to reduce the global incidence of diabetes and its associated conditions. Brexit preparedness, precious metal catalysis, and post-pandemic pharma are all discussed in In My View. And finally, we sit down with Will Downie, CEO of Vectura Group, UK.

Register to download
Register here to download any issue of The Medicine Maker for FREE.
Login
Forgot your password?
Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Articles featured in this issue

 Discovery & Development Vaccines

Beyond the Storm

| Stephanie Vine

What lies beyond COVID-19? There are many diseases that could benefit from all the collaborative effort and funding being poured into COVID-19.

Manufacture Advanced Medicine

Informing Consent

| James Strachan

Are seriously ill patients vulnerable to overestimating the benefits and underestimating the risks of gene editing studies?
Manufacture Advanced Medicine

Advanced Medicine in Brief

| James Strachan

A $4-billion acquisition, a key finding for sarcopenia drug development, and algorithmic efficiency… What’s new in advanced medicine?
Manufacture Advanced Medicine

Allogenic Advance

| James Strachan

A step closer to an off-the-shelf CAR T cell therapy.
Discovery & Development Drug Discovery

Poisoning Pain

| Maryam Mahdi

Exploring a new approach to treating IBS pain.
Discovery & Development Drug Discovery

Mass Spec Meets Machine learning

| Stephanie Vine

Can machine learning offer mass spectrometry a boost for drug discovery?
Discovery & Development Clinical Trials

Green Trials

| Stephanie Vine

Implementing green practices in clinical trials.
Business & Regulation Business Practice

Brexit Trading Unknowns

| Nik Kotecha

Is your business prepared for Brexit? Here’s some advice from Nik Kotecha.
Manufacture Contract Manufacturing Services

Precious Metal Catalysts: The Scavengers’ Guide

| Philip Wheeler, Dirk Rickert, Thorsten Rieke

Platinum group (and other precious) metal catalysts are inherently expensive, so why not recover and recycle?
Business & Regulation Business Practice

The Pandemic Diaries

| Erik Haeffler, Don O’Callaghan, Amélie Boulais

We ask medicine makers around the world to tell us how their professional and personal lives have changed over the course of the COVID-19 crisis.
Manufacture Bioprocessing - Upstream & Downstream

A Grueling Environment

| Phil Williams

NASA ultimately wants to send humans to Mars – and those humans will need medicines.
Manufacture Technology and Equipment

The Astropharmacy Concept

| Stephanie Vine

How do we make medicines in space? Lynn J. Rothschild explains how biologic medicines can be made on demand.

Manufacture Bioprocessing - Upstream & Downstream

Down to Earth

| Phil Williams

How can technologies for making medicines on demand in space be applied to Earth?
Discovery & Development Drug Delivery

Extraterrestrial Risk

| Stephanie Vine

What biosecurity risks do exo-microorganisms pose?
Manufacture Bioprocessing - Upstream & Downstream

Bringing Bioreactors to Space

| Richard Bonocora

Is it possible to design a bioreactor that can function in microgravity?

Mapping Out MAM

| Sponsored by Thermo Fisher Scientific

Amgen has brought the Multi-Attribute Method (MAM) into the mainstream, but what’s next for this analytical workflow. Click to read article
Manufacture Vaccines

Preparing for the Next Pandemic

| Stephanie Vine

A look at the past, present, and future of vaccine production – and how COVID-19 changes the outlook.
Discovery & Development Analytical Science

From Big Pharma to New Green Horizons: Lessons Learned with Ross Burn

| Ross T. Burn

Ross Burn presents the story behind his career, including setting up a company on process chemistry and his views on industry 4.0.
Manufacture Bioprocessing - Upstream & Downstream

Fighting Viruses with Enhanced ADCC

| Andrew J Racher

Researchers are always looking for new ways to improve effectiveness of antibody therapy.
Discovery & Development Drug Discovery

Diabetes: Finding a Panacea

| Maryam Mahdi

How can we effectively manage the treatment of type 1 diabetes?
Manufacture Contract Manufacturing Services

Getting the Job (Done)

| Stephanie Vine

Sitting Down With… Will Downie, CEO of Vectura Group, UK, to discuss his career and passion for business.

Other issues of 2020